Related Experiment Video
Updated: Mar 18, 2026

09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.8K
Racial differences in Emergency Department visits for seizures
Tadeu A Fantaneanu1, Shelley Hurwitz2, Katherine van Meurs1
1Department of Neurology, Brigham and Women's Hospital, United States.
Seizure
|June 27, 2016
Summary
Black patients with seizures had more emergency department visits and were less likely to receive regular care compared to white patients. This suggests potential racial disparities in seizure management and access to care.
Area of Science:
- Neurology
- Public Health
- Health Services Research
Background:
- Seizures are a frequent cause for emergency department (ED) visits.
- Existing research indicates racial and ethnic disparities in seizure care.
- Understanding these disparities is crucial for improving patient outcomes.
Purpose of the Study:
- To identify racial and clinical characteristics of patients presenting to the ED with seizures.
- To determine factors associated with repeat ED visits for seizure management.
- To investigate potential disparities in seizure care based on race.
Main Methods:
- Retrospective study of ED visits for seizures between January 1, 2008, and December 31, 2008.
- Comparison of clinical data between Black and White patients.
- Logistic regression analysis to identify factors associated with repeat ED visits.
Main Results:
- Black patients were more likely to have non-private insurance and less likely to have regular ambulatory care.
- Black patients were more likely to have multiple ED visits for seizures within the year.
- Missed or ran out of antiepileptic drugs (AEDs) was a more frequent precipitant for ED visits in Black patients.
Conclusions:
- Significant clinical differences exist between Black and White patients presenting to the ED for seizures.
- Black patients experienced a higher rate of multiple seizure-related ED visits compared to White patients.
- Findings suggest potential racial disparities in access to care for seizure management.
Related Concept Videos
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K

